Aprea Therapeutics (APRE) Marches Ahead, Up 130% In Nearly 3 Months

Aprea Therapeutics Inc. (APRE), which closed at a new high of $47.44 on Thursday, gaining nearly 20%, has more than doubled in value since its IPO on October 3, 2019.

from RTT - Biotech https://ift.tt/2tWnoar
via IFTTT